OPEN END TURBO LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 04:53:31 13/05/2024 pm IST | ||
| 1.37 EUR / 1.42 EUR | +3.33% |
|
| Current month | -6.90% | ||
| 1 month | +55.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 1.36 | +0.74% | 0 |
| 10/24/10 | 1.35 | -1.46% | 0 |
| 09/24/09 | 1.37 | +8.73% | 0 |
| 08/24/08 | 1.26 | 0.00% | 0 |
| 07/24/07 | 1.26 | +6.78% | 0 |
Delayed Quote Börse Stuttgart
Last update May 13, 2024 at 02:19 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME4SK5 |
| ISIN | DE000ME4SK53 |
| Date issued | 06/12/2023 |
| Strike | 124.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.66 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.01 € |
|---|---|
| Lowest since issue | 0.189 € |
| Spread | 0.05 € |
| Spread % | 3.52% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat
